# Effect of Rosuvastatin Therapy on HDL2 Level

> **NCT02593487** · PHASE4 · UNKNOWN · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Hyperlipemia
- Coronary Heart Disease

## Interventions

- **DRUG:** Rosuvastatin 10mg/d group
- **DRUG:** Rosuvastatin 20mg/d group

## Key facts

- **NCT ID:** NCT02593487
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2016-12
- **Final completion:** 2017-06
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2015-11-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593487, "Effect of Rosuvastatin Therapy on HDL2 Level". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02593487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*